학술논문
Canonical Thrombopoietin Receptor Mutants in Myeloproliferative Neoplasms Rely Differently on the Extracellular Domain of the Receptor but Share Similar Mechanisms of Inactivation: An Open Field for the Development of New Therapies
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:8736-8737
Subject
Language
ISSN
0006-4971